Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Observational Study of the Prognosis in Treated Arterial Hypertension

This study has been completed.
Information provided by:
Odense University Hospital Identifier:
First received: September 13, 2005
Last updated: NA
Last verified: July 2004
History: No changes posted
Observational study of life time prognosis for persons medically treated for arterial hypertension, according to current WHO-guidelines.

Condition Intervention
Drug: antihypertensive drugs according to current guidelines

Study Type: Observational
Study Design: Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Observational Study of the Prognosis in Treated Arterial Hypertension

Further study details as provided by Odense University Hospital:

Estimated Enrollment: 1000
Study Start Date: January 1970
Estimated Study Completion Date: July 2004

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

hypertension according to WHO-defined criteria

Exclusion Criteria:

age < 18 years


  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00225030

Medicial Dept. C, Odense University Hospital
Odense, Denmark, DK-5000
Sponsors and Collaborators
Odense University Hospital
Principal Investigator: Michael Strate, MD
  More Information

Publications: Identifier: NCT00225030     History of Changes
Other Study ID Numbers: SHAP-DK 
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: Denmark: National Board of Health

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases
Antihypertensive Agents processed this record on October 21, 2016